The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens
Author(s) -
Milan Čižman,
Marko Pokorn,
Katja Seme,
Andreja Oražem,
Metka Paragi
Publication year - 2001
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/47.4.475
Subject(s) - streptococcus pneumoniae , moraxella catarrhalis , haemophilus influenzae , microbiology and biotechnology , streptococcus pyogenes , moraxella (branhamella) catarrhalis , macrolide antibiotics , ketolide , moraxella , biology , medicine , erythromycin , antibiotics , bacteria , staphylococcus aureus , genetics
The correlation between increased macrolide consumption and the resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to macrolides in Slovenia from 1994 to 1999 was evaluated. The outpatient consumption of macrolides increased from 1.89 to 3.84 defined daily doses (DDD)/1000 inhabitants/day during the observation period. This increase in macrolide consumption was paralleled by a steady increase in macrolide resistance in S. pyogenes (from 0 to 7.4%, r = 0.90, P = 0.014) and upper respiratory S. pneumoniae isolates (from 0 to 9%, r = 0.82, P = 0.044). In other pathogens studied, no significant increase was detected.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom